Marion V Guerin (Marion V Guérin)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Immune Response

Dendritic Cells

Neoadjuvant Chemotherapy

Top Venues

The Journal of experimental medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Mathilde Ruggiu, Marion V Guerin, Béatrice Corre, Margot Bardou, Ruby Alonso, Cornelia Halin, Zacarias Garcia, Lea Feldmann, Fabrice Lemaître, Mathilde Dusseaux, Capucine L Grandjean, Philippe Bousso
Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes. The Journal of experimental medicine 221 (4) (2024)
Mathilde Ruggiu, Marion V Guerin, Béatrice Corre, Margot Bardou, Ruby Alonso, Cornelia Halin, Zacarias Garcia, Lea Feldmann, Fabrice Lemaître, Mathilde Dusseaux, Capucine L Grandjean, Philippe Bousso
Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes. The Journal of experimental medicine 221 (4) (2024)
Anaïs Vermare, Marion V Guerin, Elisa Peranzoni, Nadège Bercovici
Dynamic CD8 + T Cell Cooperation with Macrophages and Monocytes for Successful Cancer Immunotherapy. Cancers 14 (14) (2022)
Marion V Guerin, Fabienne Regnier, Maxime Thoreau, Lene Vimeux, Matthieu Benard, Estelle Dransart, Hweixian L Penny, Ludger Johannes, Alain Trautmann, Nadège Bercovici
Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse. Journal for immunotherapy of cancer 8 (2) (2021)
Marion V Guerin, Veronica Finisguerra, Benoit J Van den Eynde, Nadège Bercovici, Alain Trautmann
Preclinical murine tumor models: a structural and functional perspective. eLife 9 (2020)
Marion V Guerin, Fabienne Regnier, Vincent Feuillet, Lene Vimeux, Julia M Weiss, Georges Bismuth, Grégoire Altan-Bonnet, Thomas Guilbert, Maxime Thoreau, Veronica Finisguerra, Emmanuel Donnadieu, Alain Trautmann, Nadège Bercovici
TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors. Nature communications 10 (1) (2019)